Founders of Proventus Announce Its Acquisition of Becker Microbial Products
Innovative biotech company founders acquire another industry powerhouse.
SAINT-LAURENT, Quebec, October 25, 2022 (Newswire.com) - Vincent DeLorenzo and Peter Bozel, the founders of Proventus Bioscience, are proud to announce their acquisition of Becker Microbial Products (BMP), a privately-owned American company.
Like Proventus, BMP's own company discoveries with microbial research have made significant positive impacts on sustainability. They continue to strive to improve their process and products for the modern market.
BMP will continue its operations in Parkland, Florida, as the acquisition blends into Proventus' current business platform.
"We're happy to be carrying the legacy [of BMP] forward," said Mr. DeLorenzo. Go to www.proventusbioscience.com for more information.
About Becker Microbial Products (BMP)
BMP began investing in biotechnology in 1985 and has since expanded globally with distributors in Australia, France, India, Italy, South Africa, Spain, and Turkey.
Best known for combating mosquitoes, blackflies, and other pests in agriculture and forestry, BMP's formulations are produced from two proprietary strains of Bacillus thuringiensis to create award-winning pesticides.
BMP's biopesticides have made major strides in controlling both the Zika virus and the West Nile virus. They have gained global recognition in the marketplace for their effectiveness.
About Dr. Terry L. Couch
For more than 40 years, Dr. Couch was involved in the development of microbial pesticides for the betterment of public health and agriculture. He is globally recognized for his significant impact in the field, cited as a pioneer in bacterial insecticides.
Dr. Couch received his Ph.D. in entomology in 1970 from Penn State University and spent the beginning of his postdoctoral career with Abbott Laboratories as a senior research entomologist.
After pioneering new bacterial pesticides with Abbott, Dr. Couch became the President and CEO of BMP. He went on to create 10 products based off of the B. thuringiensis strains.
In 2015, Dr. Couch was nominated for the American Mosquito Control Association (AMCA) Awards.
Dr. Couch remains a vital shareholder of BMP as the founder and father of their products.
About Lawrence M. Couch
Mr. Lawrence "Larry" M. Couch is the founder and owner of LMC Microbials Consulting, LLC. He attended Florida State University. Mr. Couch joined Becker Microbial Products alongside his father in 2007 to help run the company. He continues his father's legacy as both Head of Logistics for BMP's day-to-day operations and as Proventus' Technical Sales Representative for BMP.
For press inquiries, please contact info@proventusbioscience.com.
Source: Proventus Bioscience